drugset / Trial / NCT03306940

Botulinum Toxin A in the Treatment of Hemifacial Spasm

NCT03306940

Unknown 50 enrolled Tongji University
RandomizedParallel-groupSingle-blindTreatment

Summary

Hemifacial spasm patients who received botulinum toxin A injection were divided into two groups. Group A received unilateral injection while group B received bilateral injection. Patients completed follow-up A researcher record facial videos and analyzed facial symmetry and completed 3 scales.

Timeline

Start
2017-10-02
Primary completion
2018-07-31
Completion
2018-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 1.25 iu Other
Subject Botulinum toxin type A Protein / enzyme biologic 2.5 iu Other
Subject Botulinum toxin type A Protein / enzyme biologic 3.75 iu Other

Indications